# Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery

> **NCT07348328** · NA · NOT_YET_RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 1000 (estimated)

## Conditions studied

- Cardiovascular Surgical Procedures
- Major Adverse Cardiovascular Events (MACE)

## Interventions

- **DRUG:** Compound Vitamin B tablet
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT07348328
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348328, "Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07348328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*